Kolexia
Poissy Julien
Anesthesie-réanimation
Hôpital Roger Salengro
Lille, France
190 Activités
164 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Maladie grave Pneumopathie infectieuse Infections à coronavirus Candidose invasive Syndrome de détresse respiratoire de l'adulte Sepsie Candidose Candidémie

Industries

Gilead
9 collaboration(s)
Dernière en 2023
MSD
7 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2020
LIVE ! BY GL EVENTS
1 collaboration(s)
Dernière en 2021

Dernières activités

Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023.
Emerging infectious diseases   26 janvier 2024
Late-onset Very long-chain acyl-CoA dehydrogenase deficiency diagnosis complicated by fulminant myocarditis in adult patient
Journal of intensive medicine   05 janvier 2024
PREDICT: PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study
Essai Clinique (CHU Lille)   05 décembre 2023
DisCoVeRy: Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   24 novembre 2023
What applications for plasma endocan measurement in intensive care? A clarification.
Critical care (London, England)   17 octobre 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology   20 septembre 2023
Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death.
EBioMedicine   13 septembre 2023
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Critical care (London, England)   24 août 2023
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.
Annals of intensive care   18 juillet 2023
Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option.
Annals of intensive care   28 juin 2023